ONCOSIL MEDICAL LIMITED

ONCOSIL MEDICAL LIMITED

OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.

Oncosil Medical Limited_logo

Industry:
Organization

Address:
15 Blue Street, North Sydney, NSW, Australia Zipcode 2060

Country:
Australia

Phone:
61 2 9223 3344

Market Cap:
79.12M
Total Revenue:
2.76M
Total Assets:
24.06M
Total Cash:
21M


Key Executives
Name Title Pay Year Born
Mr. Karl David Pechmann CFO & Company Sec. 305,310$ N/A
Mr. Nigel Lange CEO, MD & Pres of EMEA N/A N/A
Mr. Michael Warrener Global Sales & Marketing Director N/A N/A
Dr. David Charles James Global Head of Manufacturing Operations N/A N/A
Mr. Charles Rowland Pres of US Operations N/A 1951(69 years old)
Dr. Ralph Peters Chief Medical Officer N/A N/A
Mr. David Turner Head of Medical Affairs N/A N/A



Financial & Stock
Exchange ASX. Currency in AUD. Market state CLOSED
According to Oncosil Medical Limited's financial reports the company's revenue in 2020 were 2.76M an decrease(-33.33%) over the years 2019 revenue that were of 3.63M. In 2020 the company's total earnings were -4.26M while total earnings in 2019 were -8.57M(-50%).
Company's stock symbol is OSL.AX. Lastest price : 0.0980. Total volume :956.14k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.oncosil.com.au

  • Host name: 116.118.247.55
  • IP address: 116.118.247.55
  • Location: Australia
  • Latitude: -33.494
  • Longitude: 143.2104
  • Timezone: Australia/Sydney

Loading ...
Loading ...


More informations about "Oncosil Medical Limited" on Search Engine

OncoSil Medical – transforming the prognosis

Oncosil.com “I am excited by the opportunity to lead OncoSil Medical as it transitions into a commercial-stage medical device company. Having joined 8 months ago, I truly believe that the Company is set for an exciting future, with an impressive product that addresses such an important unmet medical need.”

OncoSil Medical – transforming the prognosis

Oncosil.com OncoSil Medical Ltd is a publicly traded biotechnology company (ASX: OSL) …

OncoSil Medical – transforming the prognosis

Oncosil.com OncoSil Medical Ltd is a publicly traded biotechnology company on the Australian …

OncoSil Medical – transforming the prognosis

Oncosil.com OncoSil Medical Limited The format of the Corporate Governance Statement is based …

At OncoSil Medical we’re committed to transforming the

Oncosil.com Dr. Roger Aston, BSc (Hons) PhD serves as a Non-Executive Director of OncoSil Medical. He has had extensive experience on boards of many biotechnology and pharmaceutical companies, and has been CEO of Pitney Pharmaceuticals Ltd, pSiMedica, pSiOncology PTE Ltd, Peptech Ltd and Cambridge Antibody Technology.

Oncosil Medical Limited (ASX:OSL) - Shares, Dividends

Intelligentinvestor.com.au Apr 06, 2021 · Oncosil Medical Limited (OSL, NeuroDiscovery Ltd) is an Australian based and ASX listed medical device company focused on localised treatments for patients with pancreatic and liver cancer.

A Look At OncoSil Medical's (ASX:OSL) Share Price Returns

Finance.yahoo.com At this point some shareholders may be questioning their investment in OncoSil Medical Limited , since the last five years saw the share price fall 36%. The falls have accelerated recently, with ...

Here's why the Oncosil Medical (ASX:OSL) share price has

Fool.com.au Nov 05, 2020 · Oncosil is focused on localised treatments for patients with pancreatic and liver cancer. Its lead product is a first class medical device with target radioactive isotope, which is implanted directly into a patient’s pancreatic tumours via an endoscopic ultrasound.

ONCOSIL MEDICAL LTD OSL(ASX) - ASX Share Price & News

Hotcopper.com.au HotCopper has news, discussion, prices and market data on ONCOSIL MEDICAL LTD. Join the HotCopper ASX share market forum today for free.

A Pilot Study of OncoSil™ Given to Patients With

Clinicaltrials.gov Dec 26, 2016 · OncoSil Medical Limited: ClinicalTrials.gov Identifier: NCT03003078 Other Study ID Numbers: ONC01P03 : First Posted: December 26, 2016 Key Record Dates: Last Update Posted: October 26, 2020 Last Verified: March 2020 Individual Participant Data …

ONCOSIL MEDICAL LTD (ASX:OSL) - Ann: OncoSil FY21 half

Hotcopper.com.au OncoSil FY21 half yearly review. There are 9 sites now just in greater London and 2 in New Zealand. By mid feb based on current roll out plan in UK which has started already all high risk people (over 70 and frontline) will be offered the vaccine.

ONCOSIL MEDICAL LTD OSL(ASX) - ASX Share Price & News

Hotcopper.com.au ONCOSIL MEDICAL LTD; Viewed 10,240 times by 3014 users (Last 30 days) Created with Sketch. Email; Created with Sketch. Print; OSL. Click for more information. 1.01% 10.0¢ ONCOSIL MEDICAL LTD - Discussion. Market Cap $79.92M ! Created with Sketch. Add to …

Oncosil Medical Ltd, OSL:ASX profile - FT.com

Markets.ft.com OncoSil Medical Limited is a late-stage medical device company, which is focused on localized treatments for patients with pancreatic and liver cancer. The Company is …

OncoSil Medical | LinkedIn

Linkedin.com OncoSil Medical is an Australian biotechnology company focused on Interventional Oncology. We’re driven to do better for patients and their families living with unmet medical needs and by a...

OncoSil Medical Ltd - Company Profile and News - Bloomberg

Bloomberg.com OncoSil Medical Limited is an Australian-based medical device company that develops and commercializes medical products to treat pancreatic and liver cancer. The …

OSL.AX - Oncosil Medical Ltd Profile | Reuters

Reuters.com OncoSil Medical Limited is a late-stage medical device company, which is focused on localized treatments for patients with pancreatic and liver cancer. The Company is …

Oncosil Medical Ltd (ASX:OSL) Share Price - Market Index

Marketindex.com.au Oncosil Medical Limited (OSL, NeuroDiscovery Ltd) is an Australian based and ASX listed medical device company focused on localised treatments for patients with pancreatic and liver cancer.

Oncosil Medical Ltd (OSL : ASX) Stock Price & News

Google.com Get the latest Oncosil Medical Ltd (OSL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Stock | ONCOSIL MEDICAL Stock Price Today | Markets Insider

Markets.businessinsider.com Feb 11, 2021 · OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It engages in the development of novel and safer radiation therapy treatments.

OSL:ASE Stock Quote - OncoSil Medical Ltd - Bloomberg Markets

Bloomberg.com OncoSil Medical Limited is an Australian-based medical device company that develops and commercializes medical products to treat pancreatic and liver cancer. The …

Oncosil Medical Ltd, N6A:DEU profile - FT.com

Markets.ft.com OncoSil Medical Limited is a late-stage medical device company, which is focused on localized treatments for patients with pancreatic and liver cancer. The Company is engaged in the development of its lead product candidate, the OncoSil localized radiation therapy, for the treatment of pancreatic cancer.

OSL.AU | OncoSil Medical Ltd. Company Profile & Executives

Wsj.com OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It engages in the development of novel and safer radiation therapy treatments.

OSL share price and company information for ASX:OSL

Www2.asx.com.au View today’s OSL share price, options, bonds, hybrids and warrants. View announcements, advanced pricing charts, trading status, fundamentals, dividend information, peer …

OSL Stock Price | OncoSil Medical Ltd. Stock Quote

Marketwatch.com OncoSil Medical Ltd. OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It engages in the development of novel and safer radiation therapy...

OSL-AU: Oncosil Medical Ltd - Stock Price, Quote and News

Cnbc.com OncoSil Medical Limited is a late-stage medical device company, which is focused on localized treatments for patients with pancreatic and liver cancer. The Company is …

OSL - OncoSil Medical Limited - Strawman: ASX share price

Strawman.com Sydney, Australia –22 October 2020: OncoSil Medical Ltd (ASX: OSL) (OncoSilor the Company), is pleased to announce that it has achieved first revenues after its first commercially treated patient was implanted with the OncoSil™device in New Zealand on 21 October 2020. This is a very significant achievement for OncoSil and marks the Company ...

How Much is OncoSil Medical Limited's (ASX:OSL) CEO

Finance.yahoo.com According to our data, OncoSil Medical Limited has a market capitalization of AU$68m, and paid its CEO total annual compensation worth AU$883k over the year to June 2019.

Michael Warrener, Oncosil Medical Ltd: Profile and

Bloomberg.com OncoSil Medical Limited is an Australian-based medical device company that develops and commercializes medical products to treat pancreatic and liver cancer. The Company's trademark product ...

Oncosil Medical Limited (ASX:OSL) - Announcements

Intelligentinvestor.com.au Oncosil Medical Limited (OSL) Announcements. Read detailed company information and latest announcements from Oncosil Medical Limited including news headlines & gain/loss. Find out more at Intelligent Investor

OSL | OncoSil Medical Ltd. Profile | MarketWatch

Marketwatch.com OncoSil Medical Ltd. It engages in the development of novel and safer radiation therapy treatments. The company was founded by David McAuliffe on April 14, 2005 and is headquartered in North ...

ONCOSIL MEDICAL LTD (N6A.F) Stock Price, News, Quote

Finance.yahoo.com Find the latest ONCOSIL MEDICAL LTD (N6A.F) stock quote, history, news and other vital information to help you with your stock trading and investing.

OncoSil Medical Ltd (ASX:OSL) - Price, Chart

Freshequities.com OncoSil Medical Limited (OSL, NeuroDiscovery Ltd) is an Australia-based company which is engaged in the development of an innovative brachytherapy (internal radiotherapy) product, OncoSil, for the treatment of pancreatic cancer, after its acquisition of Enigma Therapeutics Ltd, a …

OSL Stock Forecast, Price & News (OncoSil Medical)

Marketbeat.com OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer.

OSL ASX Company Announcements | Oncosil Medical Limited | AFR

Afr.com Mar 03, 2021 · Oncosil Medical Limited Follow The development and commercialisation of its lead product candidate, the OncoSil localised radiation therapy for the treatment of …

How Much is OncoSil Medical Limited's (ASX:OSL) CEO

Ca.news.yahoo.com Is OncoSil Medical Limited Growing? Over the last three years OncoSil Medical Limited has seen earnings per share (EPS) move in a positive direction by an average of 6.5% per year (using a line of best fit). Its revenue is down 33% over last year.

How Many OncoSil Medical Limited (ASX:OSL) Shares Did

Finance.yahoo.com While OncoSil Medical insiders bought shares last year, they didn't sell. They paid about AU$0.073 on average. We don't deny that it is nice to see insiders buying stock in the company.

OSL | OncoSil Medical Ltd. Stock Price & News - WSJ

Wsj.com View the latest OncoSil Medical Ltd. (OSL) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Is OncoSil Medical Limited (ASX:OSL) A Financially Sound

Finance.yahoo.com The direct benefit for OncoSil Medical Limited (), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital.However, the trade-off is OSL ...

OSL.AU | OncoSil Medical Ltd. Financial Statements - WSJ

Wsj.com OncoSil Medical Ltd. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View OSL.AU financial statements in full.

Oncosil Medical Ltd, N6A:STU summary - FT.com

Markets.ft.com OncoSil Medical Limited is a late-stage medical device company, which is focused on localized treatments for patients with pancreatic and liver cancer. The Company is engaged in the development of its lead product candidate, the OncoSil localized radiation therapy, for the treatment of pancreatic cancer.

How Much is OncoSil Medical Limited's (ASX:OSL) CEO

Au.news.yahoo.com Is OncoSil Medical Limited Growing? Over the last three years OncoSil Medical Limited has seen earnings per share (EPS) move in a positive direction by an average of 6.5% per year (using a line of ...

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

Nextbiotech.com.au May 04, 2020 · Share Price: $0.11 Market Capitalisation: $68.3 million Cash position: $4.8 million (at 31 March 2020) – excludes funding from recent capital raise) OncoSil Medical’s (ASX:OSL) lead product, OncoSil TM is a targeted radioactive isotope (Phosphorus-32), that’s implanted directly into a patient’s pancreatic tumours via an endoscopic ultrasound. It is a single-use brachytherapy device ...

OncoSil™ receives CE Mark approval - Finfeed

Finfeed.com Apr 01, 2020 · OncoSil Medical Ltd has received CE Marking approval from the British Standards Institute (BSI) for its OncoSil TM device used in the treatment of locally advanced pancreatic cancer (LAPC) in combination with chemotherapy.OncoSil TM is a first in class medical device comprising microparticles containing phosphorus-32 (P-32), a pure beta-emitter radioisotope, implanted directly …

ONCOSIL MEDICAL LIMITED : Target Price Consensus and

Marketscreener.com ONCOSIL MEDICAL LIMITED analysts consensus, targets, ratings and recommendations | Australian Stock Exchange: OSL | Australian Stock Exchange

ONCOSIL MEDICAL LIMITED : All Information and News | OSL

Marketscreener.com All news about ONCOSIL MEDICAL LIMITED: 2020: Oncosil Medical Sinks 12% on CEO Termination: MT

OncoSil Medical (ASX:OSL) - Share price, News & Analysis

Simplywall.st OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. More Details. Risk Analysis. Earnings are forecast to decline by an average of 5.2% per year for the next 3 years.

OncoSil Medical Ltd. Stock Price (OSL) | Barron's

Barrons.com May 06, 2020 · View today's stock price, news and analysis for OncoSil Medical Ltd. (OSL). Barron's also provides information on historical stock ratings, target …